Argent Biopharma (AU:RGT)
ASX:RGT
Holding AU:RGT?
Track your performance easily

Argent Biopharma (RGT) Share Price & Analysis

2 Followers

RGT Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

10.87%89.13%
10.87% Insiders
― Other Institutional Investors
89.13% Public Companies and
Individual Investors

RGT FAQ

What was Argent Biopharma’s price range in the past 12 months?
Argent Biopharma lowest share price was AU$0.15 and its highest was AU$1.16 in the past 12 months.
    What is Argent Biopharma’s market cap?
    Currently, no data Available
    When is Argent Biopharma’s upcoming earnings report date?
    Argent Biopharma’s upcoming earnings report date is Feb 26, 2025 which is in 108 days.
      How were Argent Biopharma’s earnings last quarter?
      Argent Biopharma released its earnings results on Aug 30, 2024. The company reported -AU$0.231 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.231.
        Is Argent Biopharma overvalued?
        According to Wall Street analysts Argent Biopharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Argent Biopharma pay dividends?
          Argent Biopharma does not currently pay dividends.
          What is Argent Biopharma’s EPS estimate?
          Argent Biopharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Argent Biopharma have?
          Argent Biopharma has 54,272,270 shares outstanding.
            What happened to Argent Biopharma’s price movement after its last earnings report?
            Argent Biopharma reported an EPS of -AU$0.231 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.576%.
              Which hedge fund is a major shareholder of Argent Biopharma?
              Currently, no hedge funds are holding shares in AU:RGT
              ---

              Argent Biopharma Stock Smart Score

              Company Description

              Argent Biopharma

              MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Northwest Biotherapeutics
              CytoDyn
              Advaxis
              BioRestorative Therapies
              Argent Biopharma
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis